Irritable Bowel Syndrome (IBS) Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Irritable Bowel Syndrome (IBS) Treatment Market size was valued at USD 1.5 billion in 2018 and is anticipated to exhibit a CAGR of 10% over the forecast period 2021-2027.

Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder that affects the large intestine. Signs and symptoms include abdominal pain, bloating, gas, cramps, constipation, or diarrhea. There are three types of irritable bowel syndrome: IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), and mixed IBS. Treatment of irritable bowel syndrome consists of relieving stress, changing your diet, appropriate medications, and counseling. Drugs that may be used to treat irritable bowel syndrome include rifaximin, eluxadoline, lubiprostone, and linaclotide. Antispasmodics are also used to treat irritable bowel syndrome, which includes dicyclomine, peppermint oil, and hyocyamine.

Market Segments

By Type 

• IBS with Diarrhea (IBS-D) 
• IBS with Constipation (IBS-C) 
• Mixed IBS

By Product 

• Rifaximin 
• Eluxadoline 
• Lubiprostone 
• Linaclotide 
• Others

Key Players

Various key players dominating the global irritable bowel syndrome treatment market comprise Valeant Pharmaceuticals International Inc., Sucampo Pharmaceuticals, Inc., Abbott Laboratories, Lexicon Pharmaceuticals, Salix Pharmaceuticals, Ironwood Pharmaceuticals, Inc., GlaxoSmithKline plc. Allergan Plc. among others.

Scope of the Report

The research study analyzes the global Irritable Bowel Syndrome (IBS) Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Irritable Bowel Syndrome (IBS) Treatment Market Report

1. What was the Irritable Bowel Syndrome (IBS) Treatment Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Irritable Bowel Syndrome (IBS) Treatment Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Irritable Bowel Syndrome (IBS) Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.